Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hauke Walter

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Medical Microbiology and Immunology|February 22, 2017
HIV-1 persistent viremia is frequently followed by episodes of low-level viremiaMarek Widera, Miriam Dirks, Barbara Bleekmann, et al.
Plos One|April 11, 2017
Using drug exposure for predicting drug resistance - A data-driven genotypic interpretation toolAlejandro Pironti, Nico Pfeifer, Hauke Walter, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 21, 2017
Results of the first international HIV-1 coreceptor proficiency panel testEva Heger, Rolf Kaiser, Elena Knops, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 11, 2007
Persistence of lamivudine-sensitive HIV-1 quasispecies in the presence of lamivudine in vitro and in vivoKristina Allers, Stefanie A Knoepfel, Pia Rauch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 28, 2016
Determination of Phenotypic Resistance Cutoffs From Routine Clinical DataAlejandro Pironti, Hauke Walter, Nico Pfeifer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 24, 2002
No evidence for persistence of multidrug-resistant viral strains after a 7-month treatment interruption in an HIV-1-infected individualHauke Walter, Peter Löw, Thomas Harrer, et al.
Retrovirology|May 21, 2020
Non-active site mutants of HIV-1 protease influence resistance and sensitisation towards protease inhibitorsTomas Bastys, Vytautas Gapsys, Hauke Walter, et al.
Medical Microbiology and Immunology|April 9, 2011
The SnoB study: frequency of baseline raltegravir resistance mutations prevalence in different non-B subtypesSaleta Sierra, Nadine Lübke, Hauke Walter, et al.
AIDS (London, England)|October 18, 2005
Detection of minor populations of drug-resistant HIV-1 in acute seroconvertersKarin J Metzner, Pia Rauch, Hauke Walter, et al.
Plos One|February 9, 2010
Only slight impact of predicted replicative capacity for therapy response predictionHendrik Weisser, André Altmann, Saleta Sierra, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Medical Microbiology and Immunology|February 22, 2017
HIV-1 persistent viremia is frequently followed by episodes of low-level viremiaMarek Widera, Miriam Dirks, Barbara Bleekmann, et al.
Plos One|April 11, 2017
Using drug exposure for predicting drug resistance - A data-driven genotypic interpretation toolAlejandro Pironti, Nico Pfeifer, Hauke Walter, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 21, 2017
Results of the first international HIV-1 coreceptor proficiency panel testEva Heger, Rolf Kaiser, Elena Knops, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 11, 2007
Persistence of lamivudine-sensitive HIV-1 quasispecies in the presence of lamivudine in vitro and in vivoKristina Allers, Stefanie A Knoepfel, Pia Rauch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 28, 2016
Determination of Phenotypic Resistance Cutoffs From Routine Clinical DataAlejandro Pironti, Hauke Walter, Nico Pfeifer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 24, 2002
No evidence for persistence of multidrug-resistant viral strains after a 7-month treatment interruption in an HIV-1-infected individualHauke Walter, Peter Löw, Thomas Harrer, et al.
Retrovirology|May 21, 2020
Non-active site mutants of HIV-1 protease influence resistance and sensitisation towards protease inhibitorsTomas Bastys, Vytautas Gapsys, Hauke Walter, et al.
Medical Microbiology and Immunology|April 9, 2011
The SnoB study: frequency of baseline raltegravir resistance mutations prevalence in different non-B subtypesSaleta Sierra, Nadine Lübke, Hauke Walter, et al.
AIDS (London, England)|October 18, 2005
Detection of minor populations of drug-resistant HIV-1 in acute seroconvertersKarin J Metzner, Pia Rauch, Hauke Walter, et al.
Plos One|February 9, 2010
Only slight impact of predicted replicative capacity for therapy response predictionHendrik Weisser, André Altmann, Saleta Sierra, et al.
Pageof 4